3-Hydroxyquinoline - CAS 580-18-7
Catalog: |
BB029902 |
Product Name: |
3-Hydroxyquinoline |
CAS: |
580-18-7 |
Synonyms: |
3-quinolinol; quinolin-3-ol |
IUPAC Name: | quinolin-3-ol |
Description: | 3-Hydroxyquinoline (CAS# 580-18-7) is a chemical reagent used in the preparation cyclic peptides with an antitumor functionality. Quinoline derivative as a result of the metabolism by cytochrome P 450. |
Molecular Weight: | 145.16 |
Molecular Formula: | C9H7NO |
Canonical SMILES: | C1=CC=C2C(=C1)C=C(C=N2)O |
InChI: | InChI=1S/C9H7NO/c11-8-5-7-3-1-2-4-9(7)10-6-8/h1-6,11H |
InChI Key: | IQQDNMHUOLMLNJ-UHFFFAOYSA-N |
Boiling Point: | 313 °C at 760 mmHg |
Density: | 1.26 g/cm3 |
MDL: | MFCD00169018 |
LogP: | 1.94040 |
GHS Hazard Statement: | H302 (75%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021188897-A1 | Neuroactive steroids and compositions and methods thereof | 20191205 |
WO-2021113068-A1 | Neuroactive steroids and compositions and methods thereof | 20191205 |
WO-2021105497-A1 | Small-molecule nadph oxidase 2 inhibitors | 20191129 |
US-2021147386-A1 | Pyrrolidine and piperidine compounds | 20191106 |
WO-2020257487-A1 | Glycolate oxidase inhibitors for the treatment of disease | 20190619 |
PMID | Publication Date | Title | Journal |
22807411 | 20120917 | Sensitisation of the near-infrared emission of Nd(III) from the singlet state of porphyrins bearing four 8-hydroxyquinolinylamide chelates | Chemphyschem : a European journal of chemical physics and physical chemistry |
21338078 | 20110318 | ESIPT-mediated photocycloadditions of 3-hydroxyquinolinones: development of a fluorescence quenching assay for reaction screening | Organic letters |
14977867 | 20040301 | An analysis of the regioselectivity of aromatic hydroxylation and N-oxygenation by cytochrome P450 enzymes | Drug metabolism and disposition: the biological fate of chemicals |
12685510 | 20021201 | Study of in vitro glucuronidation of hydroxyquinolines with bovine liver microsomes | Fundamental & clinical pharmacology |
11456568 | 20010131 | Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological properties | Journal of the American Chemical Society |
Complexity: | 138 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.052763847 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.052763847 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 33.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
-
[852913-16-7]
N-[3,5-Bis(trifluoromethyl)phenyl]-N-[(8a,9S)-6-methoxy-9-cinchonanyl]thiourea
-
[891016-02-7]
ML-SI3
-
[3735-92-0]
Methyl dimethyldithiocarbamate
-
[84030-20-6]
MTBD
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[35045-02-4]
Metribuzin-desamino
INDUSTRY LEADERS TRUST OUR PRODUCTS